|
Paroxysmal Nocturnal Hemoglobinuria (PNH) Highlights From ASH
At ASH, new information and data were presented on paroxysmal nocturnal hemoglobinuria (PNH)—a rare, acquired blood disease characterized by hemolytic anemia, bone marrow failure, thrombosis, and fatigue.
This accredited CME activity highlights the latest information about PNH from ASH and provides expert analysis of its clinical relevance for busy members of the care team in order to help them care for patients they may encounter with this rare condition. |
|
Video Viewpoint Strategy Session: Harnessing Immunotherapy-Based Strategies for Advanced Non–Small Cell Lung Cancer
This expert-led discussion, presented by Ticiana Leal, MD, Director of the Thoracic Medical Oncology Program at Winship Cancer Institute of Emory University, and Beth Sandy, MSN, CRNP, Thoracic Oncology Nurse Practitioner at Abramson Cancer Center of University of Pennsylvania, will focus on emerging efficacy and safety data on immunotherapy-based strategies, supportive care plans for adverse events, and optimizing care plans for the survivorship of patients with non–small cell lung cancer. ... |
|
|
MPS II Research Highlights From the WORLDSymposium (Mucopolysaccharidosis type II; MPS II; Hunter syndrome)
This accredited CME activity, led by Barbara Burton, MD, Professor of Pediatrics at Northwestern University Feinberg School of Medicine, highlights the latest research about Mucopolysaccharidosis type II (MPS II; Hunter syndrome) presented at WORLDSymposium 2022 and provides expert analysis of its clinical relevance for busy members of the care team to help them care for patients they may encounter with this rare condition. MPS II, also known as Hunter syndrome, is a rare, progressive lysosoma... |
|
|
Video Viewpoint Strategy Session: New Insights Into Preventing and Managing Chemotherapy-Induced Neutropenia
Discover recent developments in the prevention, treatment, and management of chemotherapy-induced neutropenia, including a comprehensive understanding of the risk factors and current clinical practice guidelines. This activity is presented by Gary H. Lyman, MD, MPH, FASCO, FACP, FRCP, Professor, University of Washington, and Maura Abbott, PhD, AOCNP®, CPNP, Columbia University School of Nursing. Start the activity now.
STATEMENT OF NEED
Chemotherapy-induced neutropenia (CIN) is a potent... |
|
|
Podcast: New Insights Into Preventing and Managing Chemotherapy-Induced Neutropenia
Discover recent developments in the prevention, treatment, and management of chemotherapy-induced neutropenia, including a comprehensive understanding of the risk factors and current clinical practice guidelines. This activity is presented by Gary H. Lyman, MD, MPH, FASCO, FACP, FRCP, Professor, University of Washington, and Maura Abbott, PhD, AOCNP®, CPNP, Columbia University School of Nursing. Start the activity now.
STATEMENT OF NEED
Chemotherapy-induced neutropenia (CIN) is a potent... |
|
|
Video Viewpoint Strategy Session: Emerging Checkpoint Inhibitor–Based Strategies for Advanced Endometrial Cancer
Gain expert insight and enhance your clinical knowledge with this case-based activity focusing on the pathology, treatment, and management of advanced endometrial cancer, presented by leading experts Ritu Salani, MD, Director of the Division of Gynecologic Oncology and Professor of Obstetrics and Gynecology at the University of California, Los Angeles (UCLA), and Floor Backes, MD, Professor of Obstetrics and Gynecology at The Ohio State University College of Medicine. Start the activity now!
... |
|
|
Podcast: Emerging Checkpoint Inhibitor–Based Strategies for Advanced Endometrial Cancer
This expert-led episode of Oncology Data Advisor TM, presented by leading experts Ritu Salani, MD, Director of the Division of Gynecologic Oncology and Professor of Obstetrics and Gynecology at the University of California, Los Angeles (UCLA), and Floor Backes, MD, Professor of Obstetrics and Gynecology at The Ohio State University College of Medicine.ain expert insight and enhance your clinical knowledge with this case-based activity focusing on the pathology, treatment, and management of adv... |
|
|
Hereditary Angioedema (HAE) Research Highlights: 2022 AAAAI Annual Meeting
This accredited CME activity, led by Paula Busse, MD, Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai, provides a summary of the latest information about hereditary angioedema (HAE) that was presented at the American Academy of Allergy, Asthma, & Immunology 2022 (2022 AAAAI) Annual Meeting. This program was developed to provide a concise means to share the clinically relevant information presented at the meeting with health care professionals who my care for ... |
|
Keeping Up with Advances in MS: Cases in Diagnosis and Treatment, A Case-Based Roadmap for Improved Patient Outcomes in Multiple Sclerosis
Join Edward Fox, MD, PhD, and Matthew Schindler, MD, PhD, in an interactive case-based roadmap for improved outcomes in patients with MS. In addition to addressing diagnostic challenges, Drs. Fox and Schindler share their insights into integrating advances in the pharmacologic treatment of patients with MS, focusing on the safety and efficacy of targeted therapies. |
|
|
Diagnosis and Evidence-Based Management of T-Cell Lymphoma
STATEMENT OF NEED
T-cell lymphoma (TCL) is an uncommon subtype accounting for approximately 15% of all cases of non-Hodgkin lymphoma in the United States (LRF, 2022). Compared with its B-cell counterpart, TCL has a poor prognosis and is associated with a 5-year survival rate of less than 20%. The clinical and pathologic presentations of TCL are varied and often nonspecific, making diagnosis and treatment challenging (Salem et al, 2021). In this webinar, Aaron Goodman, MD, will update clinic... |
|
|
Managing Symptom Burden and Optimizing Treatment Outcomes in Myelofibrosis
Learn more about myelofibrosis risk factors, novel therapies to slow disease progression and reduce symptoms, and strategies to maintain quality of life in this comprehensive activity presented by John Mascarenhas, MD, Professor of Medicine at Mount Sinai Icahn School of Medicine. Start the activity now!
STATEMENT OF NEED
Myelofibrosis is a rare myeloproliferative neoplasm characterized by the buildup of scar tissue in the bone marrow, leading to decreased erythropoiesis, progressive bon... |
|
|
Key Considerations in Managing Atopic Dermatitis in Black Patients
Statement of Need
Atopic dermatitis (AD), a severe form of eczema and intense pruritus, is associated with a substantial and multifaceted patient-reported burden that encompasses sleep disturbances, anxiety, depression, reduced function/productivity, and impaired quality of life. The incidence of AD is high, estimated to be approximately 15%-20% in children and 1%-3% in adults worldwide (Yong & Tay, 2017). Population studies within the United States have shown that AD disproportionately... |
|
An Illustrated Guide to Meeting the Challenges of Treating Hemophilia
In this activity, Steven Pipe, MD and Guy Young, MD introduce the unmet medical needs experienced by patients with hemophilia. They review the mechanisms of action and most recent clinical trial data for the most advanced substitution therapies (emicizumab), hemostatic rebalancing agents (concizumab, marstacimab, and fitusiran), and gene therapies. The faculty also discuss how approval of these treatments could affect patient care, and the questions that need to be addressed in ongoing phase 3... |
|
Paired Conversations: The Management of Patients With Hepatorenal Syndrome-Acute Kidney Injury: An International Perspective
This activity consists of 6 paired conversations with experts from Europe and the United States in the fields of hepatology, critical care, nephrology, and transplantation. During these paired conversations, the faculty explore revised diagnostic criteria, emerging treatment, and coordinating effective multidisciplinary care. In addition, the faculty panel collaboratively reviews a patient case where they share international perspectives on the nonpharmacological and pharmacological treatment ... |
|
|
Podcast: New Opportunities for Improved Patient Outcomes in Graft-Versus-Host-Disease
STATEMENT OF NEED
Graft-versus-host disease (GHVD) is a common complication of allogeneic hematopoietic stem cell transplant (HSCT) and a major contributor to morbidity and mortality (DeFilipp et al, 2021; Malard et al, 2020). Acute GVHD occurs within 100 days of transplant and typically targets the skin, gastrointestinal tract, and liver (LLS, 2022). Chronic GVHD often presents within the first year following HSCT but may develop in subsequent years. It most commonly affects the skin; howe... |
|
|
Diagnosis & Comorbidities in Cushing’s Disease: Incorporating the New Consensus Summary Into Your Practice
This 30 minute CME program highlights the latest expert consensus on best practices for diagnosing Cushing’s disease and managing the comorbidities commonly observed in persons with this rare disorder.
Cushing’s disease is caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary tumor. Optimal patient outcomes require an accurate diagnosis, proper selection of individualized treatment, and good management of the disease and its associated comorbidities.
The program feature... |
|
|
Updates in Medical Management of Cushing’s Syndrome: Incorporating the New Consensus Summary into Your Practice
This 30 minute CME program highlights the latest expert consensus on best practices for the treatment of persons with Cushing’s disease.
Cushing’s disease is caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary tumor. Optimal patient outcomes require an accurate diagnosis, proper selection of individualized treatment, and good management of the disease and its associated comorbidities.
The program features two experts, Maria Fleseriu, MD, Professor of Medicine and Neur... |
|
|
Advances in Gene Therapy for Lysosomal Diseases
This CME/CE activity highlights the current trends in gene therapy for lysosomal storage diseases as well as some of the safety concerns with such therapy.
This activity provides continuing education credit for Physicians, Physician Assistants, Nurse Practitioners, Nurses, Genetic Counselors as well as a statement of participation for other participants. |
|
|
Optimizing Treatment Selection, Sequencing, and Tolerability in Small Cell Lung Cancer
This case-based podcast presented by i3 Health brings together two leading experts, Anne Chiang, MD, PhD, Associate Professor of Medicine, and Henry Park, MD, MPH, Chief of the Thoracic Radiotherapy Program, both at Yale School of Medicine, who will examine recent clinical advances and new opportunities in the management of SCLC and discuss key clinical questions engendered by recent advances in treatment and the need for individualized care. Start the activity now.
Statement of Need
An ... |
|
|
Growth Hormone Deficiency Research Highlights
This 15-minute CME program highlights the latest clinical research about Growth Hormone Deficiency (GHD).
GHD is a rare endocrine disorder characterized by insufficient levels of growth hormone being secreted from the anterior pituitary gland. A hallmark of prolonged GHD is growth retardation or deceleration, as well as short stature. Additionally, growth hormone deficiency is associated with metabolic abnormalities, impaired cardiovascular function, fatigue, delayed or incomplete puberty, ... |
|
|
Cushing’s Disease / Cushing’s Syndrome Research Highlights
This 30-minute CME program highlights the latest clinical research about Cushing’s disease and Cushing’s syndrome.
Cushing’s disease is caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary tumor that leads to excessive levels of cortisol. Cushing’s syndrome is also characterized by excessive levels of cortisol but can be due to a variety of reasons.
This CME program, hosted by Richard Auchus, MD, PhD Professor at the University of Michigan, provides an overview of ... |
|
|
Evolving Treatment Concepts and New Data in Advanced Prostate Cancer
STATEMENT OF NEED
Prostate cancer is the most common tumor type affecting men in the United States. It is estimated that 268,490 new cases were diagnosed and that 34,500 people died of prostate cancer in 2022 (Siegel et al, 2022). Prostate cancer alone accounts for 27% of all cancer diagnoses in men (ACS, 2022). To optimize outcomes for patients with prostate cancer, it is critical for health care providers to be familiar with the most recent evidence on therapy selection, biomarker testing... |
|
|
Research Highlights on Pyruvate Kinase (PK) Deficiency
This accredited CME activity provides a summary of the latest information about Pyruvate kinase (PK) deficiency that was presented at the 2021 American Society of Hematology Annual Meeting (ASH 2021). Since the Covid-19 pandemic limited the ability for specialists to attend ASH 2021 and discuss this latest research, this program provides a review by Rachael Grace, MD, of the most clinically-relevant information on PK deficiency presented during the meeting.
PK deficiency is a rare genetic b... |
|
|
HIV and COVID-19: A Clinical Compendium on a Pandemic Within a Pandemic
Target Audience
This activity was developed for a national audience of HIV specialists, infectious disease specialists, primary care physicians, nurse practitioners, nurses, and other healthcare professionals who care for persons living with HIV.
Program Overview
Four case studies are discussed in this activity by Drs. Badowski and Gandhi that provide insight on challenges encountered in everyday clinical practice. Their discussion highlights recent clinical advances in the use of ant... |
|
|
Current Issues Regarding Obesity Treatment and Chronic Weight Management
Obesity experts Drs. Apovian and Kushner delve into the complex and undertreated disease of obesity, addressing the importance of weight loss and chronic weight management. They discuss obesity as a chronic disease with its pathophysiologic basis, associated cardiometabolic risks, treatment options including pharmacotherapy, focusing on incretin-based medications, optimizing weight loss and maintenance, and how to approach patients about obesity. Case studies are utilized in which the faculty ... |
|
|
1,800 Secondsâ„¢ in Emerging Therapies for Atopic Dermatitis
Target Audience
This activity is designed to meet the educational needs of dermatologists, allergists, and primary care physicians who are involved in the care and treatment of patients with AD.
Program Overview
A 30-minute (1,800 seconds) video-based online module designed to enhance clinicians’ knowledge of expanding evidence on emerging therapies for atopic dermatitis (AD).
Learning Objectives
Upon completion of this activity, participants should be better able to:
Describe th... |
|
|
Current Issues Regarding Obesity Treatment and Chronic Weight Management
Target Audience
This activity was developed for cardiologists, endocrinologists, primary care physicians, and other healthcare providers who treat patients’ obesity and other commonly associated diseases.
Program Overview
Obesity experts Drs. Apovian and Kushner delve into the complex and undertreated disease of obesity, addressing the importance of weight loss and chronic weight management. They discuss obesity as a chronic disease with its pathophysiologic basis, associated cardiometa... |
|
|
Expert Illustrations & Commentaries™: Visualizing New Therapies in Uveitic Macular Edema – Understanding Impact With an Updated Armamentarium
Activity Overview
This Expert Illustrations and CommentariesTM is a video-based program in which 2 experts discuss the etiology and management of uveitic macular edema (UME). In this activity, the faculty focus on the pathophysiology, imaging and other diagnostic strategies, and current and emerging therapies for the management of UME. Their discussion is enriched with the use of video animation to illustrate the disease process and the mechanism of action of corticosteroid therapy. The use... |
|
|
Alleviating Asthma Burden—Identifying and Managing Poorly Controlled Disease in Pediatric Patients
Activity Overview
Asthma is responsible for significant patient morbidity and mortality, and tremendous burdens on health care systems and pediatric patients with asthma can be disproportionately affected. In particular, children and adolescents with poorly controlled or severe asthma comprise a group in which unmet needs warrant concentrated attention. These patients benefit significantly from the use of targeted therapies, yet clinicians may not be implementing best-use strategies.
This ... |
|
|
All in for ALL: Mitigating VOD Risk in Patients Being Treated for R/R ALL
Are you involved with mitigating veno-occlusive disease (VOD) risk in patients with relapsed/refractory acute lymphoblastic leukemia (R/R ALL)? Are you current with the latest guidance regarding R/R ALL treatment? The therapeutic landscape for R/R ALL now comprises of a wide variety of agents. Stay abreast of the most recent R/R ALL treatment updates as well as the latest in how to manage VOD risk in patients with R/R ALL.
Host a complimentary Virtual Visiting Professorship Program designe... |
|
|
A New Path Forward: The Therapeutic Potential of Next Generation BTK Inhibitors in CLL/SLL
Targeted agents such as Bruton tyrosine kinase (BTK) inhibitors dramatically changed the treatment landscape for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). Unfortunately, challenges with tolerance and resistance are pervasive with these agents. Novel highly selective, non-covalent (reversible) BTK inhibitors that may overcome these challenges are undergoing investigation in clinical trials and have the potential to significantly enhance the treatment of CLL/SLL. In ea... |
|
|
Obstetrics and Gynecology 2023 - LIVE STREAMING
New Diagnosis and Treatment Updates in Clinical Obstetrics, Minimally Invasive Gynecologic Surgery, Urogynecology, Gynecologic Oncology, Reproductive Endocrinology, and Infertility
Obstetrics and Gynecology 2023 will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies.
OVERVIEW
This special update on diagnosis and treatment of the reproductive health of women across their lifespan, designed and presented by Harvard Medical Schoolâ... |
|
|
Monoclonal Antibodies for COVID-19: New Avenues to Pre-Exposure Prophylaxis - Activity 2: Immunocompromised Patients and COVID-19 Risks
As the COVID-19 pandemic continues to devastate the world, it is important for clinicians to recognize the most vulnerable populations, such as immunocompromised people. They are unlikely to mount a full response to COVID-19 vaccinations and have a higher risk of both severe outcomes if infected and easier transmission to uninfected people. An Emergency Use Authorization (EUA) was recently granted for preexposure prophylaxis in immunocompromised people, and it is critical that clinicians are a... |
|
|
Principles of Medical Education: Maximizing Your Teaching Skills - LIVE STREAMING
The Techniques and Strategies that Significantly Improve Student Engagement and Teaching and Mentoring Effectiveness
OVERVIEW
Incorporating best practices, newer principles of adult learning, and widely available technologies into your teaching can significantly improve your ability to engage and inspire students, residents, fellows, and colleagues. This special program, ranked among Harvard Medical School’s highest-rated CME courses, is a uniquely comprehensive exploration of best pract... |
|
|
A NEW DAWN IN ALZHEIMER’S DISEASE MANAGEMENT? Recent Advances in Diagnosis and Treatment
Program Overview
With the number of Alzheimer’s disease (AD) specialists limited in many parts of the country, many primary care physicians (PCPs) must provide care, often beyond their level of training or expertise, for patients with AD or early signs of AD. Too often early signs and symptoms of AD are missed or not given appropriate priority, and thus specialty referrals occur later in the course of disease. Furthermore, the difficulty in diagnosing AD and the lack of any disease modify... |
|
|
Optimizing Multiple Sclerosis Care in the General Neurology Setting Newer Monoclonal Antibodies
Target Audience
General neurology physicians, PAs, nurse practitioners, nurses, and other healthcare professionals involved in the treatment of patients with MS.
Program Overview
Dr. James Bowen and Dr. Sally Harris review and discuss the newer monoclonal antibodies, ocrelizumab and ofatumumab.
Learning Objectives
Upon completion of this activity, participants should be better able to:
Review the efficacy and safety data for newer MS therapies to facilitate evidence-based care
Ide... |
|
|
Medical Crossfire®: The Role of Inflammation in the Treatment of Diabetic Macular Edema – Expert Insights and Case Considerations
Target Audience
This online educational activity is directed toward ophthalmologists and retinal specialists. Optometrists and other health care professionals involved in the treatment of patients with DME are also invited to participate.
Program Overview
Diabetes mellitus (DM) currently affects 34 million people in the United States. Diabetic retinopathy is the most common ocular complication of DM and is the leading cause of blindness among working-age adults. The primary cause of visua... |
|
|
Community Practice Connections™: Bridging the Gap in Multiple Sclerosis—A Focus on Clinical and Health Care Disparities in Racial-Ethnic Patient Populations
Target Audience
This educational activity is directed toward neurologists, MS subspecialists, nurse practitioners, physician assistants, registered nurses and other health care professionals involved in the management of patients with MS.
Program Overview
Disparities in health care disproportionally affect members of underserved or underrepresented racial and ethnic backgrounds, limiting access to care and health outcomes. The multiple sclerosis (MS) community is not immune to this challe... |
|
|
Monoclonal Antibodies for COVID-19: New Avenues to Pre-Exposure Prophylaxis - Activity 3: Point-of-Care Use of Anti-SARS-CoV-2 Monoclonal Antibodies as Pre-Exposure Prophylaxis
As the COVID-19 pandemic continues to devastate the world, it is important for clinicians to recognize the most vulnerable populations, such as immunocompromised people. They are unlikely to mount a full response to COVID-19 vaccinations and have a higher risk of both severe outcomes if infected and easier transmission to uninfected people. An Emergency Use Authorization (EUA) was recently granted for preexposure prophylaxis in immunocompromised people, and it is critical that clinicians are a... |
|
|
Telemedicine Talk Prediabetes and Obesity: Broaching the Weight Loss Talk
Target Audience
This activity has been designed for clinicians interested in the management of patients with obesity. Specialties include primary care providers, cardiologists, endocrinologists, obstetricians/gynecologists, and rheumatologists.
Program Overview
Obesity continues to become more prevalent in the United States, and with it, patients’ health and quality of life are diminished by increased incidence of conditions such as obstructive sleep apnea. The majority of clinician... |
|
|
Telemedicine Talk Diet and Lifestyle in Managing Cardiac Conditions and Obesity
Target Audience
This activity has been designed for clinicians interested in the management of patients with obesity. Specialties include primary care providers, cardiologists, endocrinologists, obstetricians/gynecologists, and rheumatologists.
Program Overview
Obesity continues to become more prevalent in the United States, and with it, patients’ health and quality of life are diminished by increased incidence of conditions such as obstructive sleep apnea. The majority of clinician... |
|
|
Sports Medicine 2023 -LIVE STREAMING
The Comprehensive 2023 Sports Medicine Update
State-of-the-Art Approaches to the Diagnosis, Treatment, Rehabilitation, and Prevention of Sports Injuries
This Harvard Medical School CME program, which is among the highest-rated HMS CME courses, provides a special and timely opportunity to hear directly from world-renowned physician specialists (physiatrists, orthopedists, radiologists), team physicians and athletic trainers for the Boston Red Sox, Boston Bruins, New England Revolution and... |
|
|
Effective PCSK9 Inhibitor Therapy Starts With You: Overcoming Barriers to Patient Access
Target Audience
This activity has been designed to meet the educational needs of primary care physicians and cardiologists.
Program Overview
This activity will review the role of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition in patients with primary and secondary hyperlipidemia, citing the latest evidence from care guidelines and clinical trials, and highlighting the importance of continuing PCSK9 inhibitor therapy as well as standard of care agents for patients at high... |
|
|
Detection and Mitigation of Amyloid-Related Imaging Abnormalities (ARIA) in Alzheimer’s Disease Patients
Target Audience
This activity is designed to meet the educational needs of physicians, neurologists, geriatricians, psychiatrists, nurse practitioners, physician assistants and nurses.
Program Overview
Ongoing research into the use of immunotherapy to treat AD has resulted in the identification of amyloid-related imaging abnormalities (ARIA) as potential side effects of therapy, and spontaneous complications in certain types of AD. As most patients who develop ARIA are asymptomatic, it is... |
|
|
https://learning.freecme.com/a/39511PHiMAY
Target Audience
The intended audience for this activity program are primary care physicians, internists, family physicians, nurses, physician assistants, nurse practitioners in primary care practices, oncologists, and hematologists.
Learning Objectives
Upon completion of this activity, participants should be better able to:
Distinguish between current MCED tests, trial designs, and clinical data
Evaluate practical considerations and new workflows to improve integration of new scre... |
|
|
Latest Data in FSGS and IgAN
Expert faculty, Dr. Richard Lafayette, explores clinical trial data coming out of a recent nephrology meeting, and provides learners with up-to-date knowledge on focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN). This brief interview-style video offers insights into the patient burden of chronic kidney disease, advances in understanding the pathophysiology, and emerging approaches to treatment for this patient population. Dr. Lafayette discusses current barriers, emerging ev... |
|
|
Individualizing Prostate Cancer Treatment: Special Considerations for Gay and Bisexual Men
This activity features a panel consisting of an oncologist and leading experts (a urologist and a researcher) in prostate cancer care considerations in gay and bisexual men (GBM), where they discuss quality of life considerations and disparities. The panel’s aim is to provide clinicians with real-world strategies to facilitate optimal communication and shared decision-making with these patients. This initiative provides the latest epidemiological and clinical data, controversies, and evolvin... |
|
|
Penn Radiology Oncologic Imaging Essentials (Online Streaming & DVD-ROM)
Penn Radiology responds to the constant challenge of Cancer imaging with Oncologic Imaging Essentials. This activity includes a review of the diagnostic imaging evaluation of common tumors, including breast, head and neck, thoracic and abdominal malignancies. Current state of the art modalities used for oncologic imaging, including CT, MRI, ultrasound, PET-CT and digital mammography will be discussed. Emphasis is placed on the role of imaging in staging, treatment and follow up in order to ... |
|
|
Provider and Caregiver Connection Live: Aligning Oncology and Cardiology Care to Identify and Manage ICI-Related Myocarditis
Target Audience
This educational activity is directed toward cardiologists and cardiology subspecialists, nurse practitioners, physician assistants, and nurses.
Program Overview
This online, on-demand virtual symposium brings together renowned experts who treat patients with immune checkpoint inhibitor (ICI)–related cardiotoxicity. These experts will discuss underlying pathophysiologic mechanisms and best practices to monitor and treat patients with ICI-related cardiotoxicity. Patient v... |
|
|
Reaching Milestones in Acid Sphingomyelinase Deficiency: Improving Outcomes with Early Diagnosis and Emerging Treatments
Target Audience
The intended audience is U.S. clinical geneticists, clinical laboratory genticists, genetic counselors, pediatricians, pediatric neurologists, hepatologists, cardiologists, internal medicine providers, primary care clinicians, physician assistants and other health care providers who may be involved in the diagnosis and management fo ASMD
Program Overview
Acid sphingomyelinase deficiency (ASMD) is a rare, progressive lysosomal storage disorder with no approved disease-s... |
|